Patents by Inventor Kim Graulich Hankey

Kim Graulich Hankey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human lymphocyte vaccine adjuvant
    Patent number: 8088397
    Abstract: The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: January 3, 2012
    Assignees: Hasumi, LLC, University of Maryland, Baltimore
    Inventors: Kenichiro Hasumi, Dean LeMar Mann, Kim Graulich Hankey, Kristina Michelle Holt
  • Human Lymphocyte Vaccine Adjuvant
    Publication number: 20100266534
    Abstract: The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
    Type: Application
    Filed: June 28, 2010
    Publication date: October 21, 2010
    Applicants: HASUMI LLC, UNIVERSITY OF BALTIMORE, MARYLAND
    Inventors: Kenichiro Hasumi, Dean LeMar Mann, Kim Graulich Hankey, Kristina Michelle Holt
  • Human lymphocyte medium adjuvant
    Patent number: 7745157
    Abstract: The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
    Type: Grant
    Filed: February 20, 2004
    Date of Patent: June 29, 2010
    Assignees: University of Maryland, Baltimore, Hasumi LLC
    Inventors: Kenichiro Hasumi, Dean LeMar Mann, Kim Graulich Hankey, Kristina Michelle Holt
  • Human lymphocyte vaccine adjuvant
    Publication number: 20040241183
    Abstract: The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
    Type: Application
    Filed: February 20, 2004
    Publication date: December 2, 2004
    Inventors: Kenichiro Hasumi, Lowell T. Harmison, Dean LeMar Mann, Kim Graulich Hankey, Kristina Michelle Holt